StockData
CFOOOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

China Foods Holdings Ltd.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.05+0.00 (0.00%)

Close on Oct 16, 2026

Market cap
$21.26M
P/E (TTM)
–
Dividend yield
–

China Foods Holdings Ltd. revenue by segment

By business segment

RevenueFY2025FY2024FY2023FY2022FY2021FY2020% of revenueYoY
Healthcare Segment [Member]$327.11K$125.55K$19.31K$180.65K$256.85K$785.86K99.8%+160.5%
Wine Segment [Member]$764$107.79K$139.16K$173.44K$104.27K$227.29K0.2%-99.3%
Operating incomeFY2025FY2024FY2023FY2022FY2021FY2020YoY
Healthcare Segment [Member]-$56.53K-$69.50K-$75.15K-$306.21K-$497.31K-$338.53K-18.7%
Wine Segment [Member]-$342.39K-$386.14K-$329.48K-$86.52K$40.88K-$132.28K-11.3%

By product or service

RevenueFY2025FY2024FY2023FY2022FY2021FY2020% of revenueYoY
Sales of Healthcare [Member]$258.80K$106.02K$3.34K$39.60K$40.00K$481.05K78.9%+144.1%
Sales of Healthcare Products [Member]$258.80K$106.02K$3.34K$39.60K$40.00K–78.9%+144.1%
Consulting Service Income [Member]$68.31K$19.52K$15.97K–$216.85K$221.04K20.8%+249.9%
Consultancy Service Fee Income [Member]$68.31K$19.52K$15.97K$141.05K$216.85K$221.04K20.8%+249.9%
Sale of Wine Products [Member]$764$107.79K$139.16K$173.44K$104.27K$311.05K0.2%-99.3%
Sale of Healthcare Products [Member]––––$40.00K$564.81K––

By region

RevenueFY2025FY2024FY2023FY2022FY2021FY2020% of revenueYoY
China$259.57K$214.11K$142.51K$213.62K$144.27K$792.10K79.2%+21.2%
Hong Kong SAR China$68.31K$19.23K$15.97K$140.48K$216.85K$221.04K20.8%+255.2%

From the segment and revenue-disaggregation notes of China Foods's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.